Tompkins Financial’s ResMed RMD Stock Holding History

Tompkins Financial’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9	Closed	-$2K	–	608
2022 Q1	$2K	Hold	9	–	–	﹤0.01%	572
2021 Q4	$2K	Buy	+9	New	+$2.33K	﹤0.01%	337
2019 Q2	–	Sell	-146	Closed	-$15K	–	392
2019 Q1	$15K	Hold	146	–	–	﹤0.01%	329
2018 Q4	$17K	Sell	146 -92	-39%	-$9.86K	﹤0.01%	310
2018 Q3	$27K	Sell	238 -102	-30%	-$11.2K	0.01%	299
2018 Q2	$35K	Hold	340	–	–	0.01%	283
2018 Q1	$33K	Buy	+340	New	+$32.1K	0.01%	277
2017 Q4	–	Sell	-55	Closed	-$4K	–	433
2017 Q3	$4K	Buy	+55	New	+$4.21K	﹤0.01%	379
2015 Q2	–	Sell	-50	Closed	-$4K	–	538
2015 Q1	$4K	Buy	+50	New	+$3.25K	﹤0.01%	490

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Tompkins Financial's RMD Position: Q2 2022 in Review

Tompkins Financial sold out of ResMed (RMD) in Q2 2022, closing a stake of 9 shares — an estimated $2K sold.

Tompkins Financial first reported a position in RMD in Q1 2015 and held it in 9 quarters. The position peaked at $35K in Q2 2018. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

Tompkins Financial reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
Tompkins Financial sold 9 ResMed shares in Q2 2022, an estimated $2K.
Tompkins Financial first reported a position in ResMed in Q1 2015 and held it in 9 quarters.
Tompkins Financial's ResMed position peaked at $35K in Q2 2018.
676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Tompkins Financial's 13F filing for Q2 2022, filed 14 Jul 2022.